Quercetin - Bioflavonoid Complex + Selenium IV
Natural health product licensed in Canada
- Licence holder
- Vitazan Herbs and Vitamins Inc
- NPN or DIN-HM
- 80120737
- Status
- Active licence
- Licence date
- 23 August 2022
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bioflavonoïdes d'agrumes Source : Citrus limon - Fruit Potency : 50 % Hesperidin | 250 mg | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus paradisi - Pelure (fruit) Potency : 50 % Hesperidin | 250 mg | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus sinensis - Écorce de fruit Potency : 50 % Hesperidin | 250 mg | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus sinensis - fruit Potency : 50 % Hesperidin | 250 mg | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus limon - Pelure (fruit) Potency : 50 % Hesperidin | 250 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 50 mg | Not calculated |
| Sélénium Source : Sélénométhionine | 100 Microgrammes | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus paradisi - Fruit Potency : 50 % Hesperidin | 250 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone Source : Styphnolobium japonicum - Bourgeon floral | 250 mg | Not calculated |
| 3-(O-6-désoxy-alpha-l-mannopyranosyl-(1-6)-bêta-d-glucopyranosyloxy)-2-(3,4-dihydroxyphényl)-5,7-dihydroxy-4H-chromen-4-one Source : Styphnolobium japonicum - Bourgeon floral | 50 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 1,800,000 FCC PU | Not calculated |
Non-medicinal ingredients
Eau purifiée, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health and normal growth and development. A factor in the maintenance of good health. Antioxidant for good health. Contributes to maintaining general health. For maintaining general health. Helps to maintain normal function of the thyroid gland. Helps to prevent selenium deficiency to help maintain normal function of the thyroid gland. Helps to prevent selenium deficiency to support biological functions which play a key role in the maintenance of good health. Helps to prevent selenium deficiency. Maintains good health. Mineral supplement. Source of/An antioxidant that helps (to): a) fight/b) protect (cells) against/c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/An antioxidant that helps protect against oxidative stress. Supports good health. Antioxidant for the maintenance of good health. Source of mineral, a factor in the maintenance of good health. Source of mineral, a factor in normal growth and development. Source of mineral to support biological functions which play a key role in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80120737
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.